• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无肝素透析:高危患者的比较数据及结果

Heparin free dialysis: comparative data and results in high risk patients.

作者信息

Caruana R J, Raja R M, Bush J V, Kramer M S, Goldstein S J

出版信息

Kidney Int. 1987 Jun;31(6):1351-5. doi: 10.1038/ki.1987.149.

DOI:10.1038/ki.1987.149
PMID:3613407
Abstract

Heparin free hemodialysis was compared to systemic heparinization, intermittent saline flushes and constant saline infusions in eight, stable chronic patients dialyzing on hollow-fiber artificial kidneys (HFAK) at blood flows of 250 to 300 ml/min. No significant differences in small molecule clearance, fluid removal or dialyzer clotting were noted. Since this data showed that heparin free hemodialysis without supplemental saline was feasible in a group of stable, chronic dialysis patients, we then prospectively studied twenty-nine patients judged to be at increased risk of hemorrhage from heparinization during 100 heparin-free dialyses. The incidences of severe and moderate dialyzer clotting were 7% and 20%, respectively. Seventeen of 27 treatments in which moderate or severe clotting occurred had identifiable factors thought to predispose to dialyzer clotting such as low blood flows, poor vascular-access function, severe hypotension and intradialytic blood transfusions. Although higher hematocrit values were associated with greater degrees of dialyser clotting, stepwise discriminant analysis employing blood flow, blood pressure, hematocrit and transfusion administration could not develop an accurate predictor or combination of predictors of clotting. No patient experienced de novo or increased bleeding and problems with inadequate dialysis were not observed. Since this method of heparin free dialysis is as safe and effective as previously reported strategies and requires no specialized equipment or procedures, it is a reasonable initial strategy for dialyzing high risk patients.

摘要

在八名使用中空纤维人工肾(HFAK)、血流速度为250至300毫升/分钟进行透析的稳定慢性患者中,对无肝素血液透析与全身肝素化、间歇性生理盐水冲洗和持续生理盐水输注进行了比较。在小分子清除、液体清除或透析器凝血方面未观察到显著差异。由于该数据表明,在一组稳定的慢性透析患者中,不补充生理盐水的无肝素血液透析是可行的,因此我们随后对29名被判定因肝素化而出血风险增加的患者进行了前瞻性研究,共进行了100次无肝素透析。严重和中度透析器凝血的发生率分别为7%和20%。在发生中度或严重凝血的27次治疗中,有17次有可识别的因素被认为易导致透析器凝血,如低血流、血管通路功能差﹑严重低血压和透析中输血。尽管较高的血细胞比容值与透析器凝血程度较高有关,但采用血流﹑血压﹑血细胞比容和输血情况进行的逐步判别分析无法得出准确的凝血预测指标或预测指标组合。没有患者出现新的出血或出血增加,也未观察到透析不充分的问题。由于这种无肝素透析方法与先前报道的策略一样安全有效,且不需要专门的设备或程序,因此对于透析高危患者来说是一种合理的初始策略。

相似文献

1
Heparin free dialysis: comparative data and results in high risk patients.无肝素透析:高危患者的比较数据及结果
Kidney Int. 1987 Jun;31(6):1351-5. doi: 10.1038/ki.1987.149.
2
Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.HepZero 研究的原理和设计:一项前瞻性、多中心、国际性、开放、随机、对照临床试验,采用平行组设计,比较无肝素透析与肝素涂层透析膜(Evodial)与标准治疗的疗效:一项随机对照试验的研究方案。
Trials. 2013 Jun 1;14:163. doi: 10.1186/1745-6215-14-163.
3
Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.使用肝素化聚丙烯腈膜和富含柠檬酸盐的透析液进行间歇性血液透析时避免全身抗凝:一项回顾性队列研究。
BMC Nephrol. 2014 Jul 3;15:104. doi: 10.1186/1471-2369-15-104.
4
Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.评估肝素涂层 AN69ST®透析器时的凝血和抗 Xa 因子。
Nefrologia. 2012;32(5):605-12. doi: 10.3265/Nefrologia.pre2012.Jun.11486.
5
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.维生素 E 涂层和肝素涂层透析器膜在无肝素血液透析中的应用:一项多中心、随机、交叉试验。
Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23.
6
Heparin-free hemodialysis with prophylactic change of dialyser and blood lines.无肝素血液透析并预防性更换透析器和血路管。
Int J Artif Organs. 1988 Jul;11(4):255-8.
7
Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.使用Cordis Dow 3500中空纤维进行无肝素输注的血液透析。
Proc Clin Dial Transplant Forum. 1980;10:39-42.
8
Hemodialysis without Systemic Anticoagulation: A Randomized Controlled Trial to Evaluate Five Strategies in Patients at a High Risk of Bleeding.无全身抗凝的血液透析:一项评估五种策略在高出血风险患者中的随机对照试验。
Med Sci (Basel). 2024 Aug 4;12(3):38. doi: 10.3390/medsci12030038.
9
Hemodialysis without anticoagulation.
Am J Kidney Dis. 1985 Jan;5(1):32-5. doi: 10.1016/s0272-6386(85)80132-3.
10
Dose titration study of tinzaparin, a low molecular weight heparin, in patients on chronic hemodialysis.低分子量肝素替扎肝素在慢性血液透析患者中的剂量滴定研究。
Artif Organs. 1998 Aug;22(8):633-7. doi: 10.1046/j.1525-1594.1998.06008.x.

引用本文的文献

1
Saline flushing to prevent circuit clotting during CRRT without anticoagulant: a randomized controlled study.无抗凝剂连续性肾脏替代治疗(CRRT)期间生理盐水冲洗预防管路凝血的随机对照研究。
BMC Nurs. 2025 Aug 25;24(1):1109. doi: 10.1186/s12912-025-03762-x.
2
Transient blood thinning during extracorporeal blood purification via the inactivation of coagulation factors by hydrogel microspheres.通过水凝胶微球使凝血因子失活实现体外血液净化过程中的短暂血液稀释。
Nat Biomed Eng. 2021 Oct;5(10):1143-1156. doi: 10.1038/s41551-020-00673-x. Epub 2021 Jan 25.
3
Does subjective assessment of dialyzer appearance reflect dialyzer performance in online hemodiafiltration?
对透析器外观的主观评估能否反映在线血液透析滤过中透析器的性能?
Hemodial Int. 2020 Jan;24(1):61-70. doi: 10.1111/hdi.12788. Epub 2019 Oct 21.
4
Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice.三级急性护理住院患者实践中常规避免使用肝素进行血液透析的前瞻性研究。
Kidney Int Rep. 2017 Mar 16;2(4):695-704. doi: 10.1016/j.ekir.2017.03.003. eCollection 2017 Jul.
5
Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.使用肝素化聚丙烯腈膜和富含柠檬酸盐的透析液进行间歇性血液透析时避免全身抗凝:一项回顾性队列研究。
BMC Nephrol. 2014 Jul 3;15:104. doi: 10.1186/1471-2369-15-104.
6
Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.无全身抗凝的血液透析:一项评估出血风险患者三种策略的前瞻性随机试验。
PLoS One. 2014 May 13;9(5):e97187. doi: 10.1371/journal.pone.0097187. eCollection 2014.
7
Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.HepZero 研究的原理和设计:一项前瞻性、多中心、国际性、开放、随机、对照临床试验,采用平行组设计,比较无肝素透析与肝素涂层透析膜(Evodial)与标准治疗的疗效:一项随机对照试验的研究方案。
Trials. 2013 Jun 1;14:163. doi: 10.1186/1745-6215-14-163.
8
Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended?间歇性生理盐水冲洗或持续性生理盐水输注:在推荐无肝素透析时哪种效果更好?
Int J Nephrol Renovasc Dis. 2013 Apr 15;6:65-9. doi: 10.2147/IJNRD.S43252. Print 2013.
9
Use and safety of heparin-free maintenance hemodialysis in the USA.美国无肝素维持性血液透析的使用和安全性。
Nephrol Dial Transplant. 2013 Jun;28(6):1589-602. doi: 10.1093/ndt/gft067. Epub 2013 Apr 5.
10
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.在维持性血液透析期间使用未分级肝素进行抗凝的使用和安全性。
Am J Kidney Dis. 2012 Sep;60(3):473-86. doi: 10.1053/j.ajkd.2012.03.017. Epub 2012 May 5.